期刊文献+

化疗栓塞对肝细胞癌癌基因ras/p21表达的影响 被引量:1

The effect of chemoembolization on ras/p21 gene expression of hepatocellular carcinoma
暂未订购
导出
摘要 目的 :研究原癌基因ras/ p2 1在肝细胞癌 (HCC)中表达的意义以及不同化疗栓塞方法对其表达的影响。 方法 :7种不同组织学类型的HCC共 98例 ,单纯手术治疗 5 7例 ,4种介入治疗后二期切除 41例。采用SABC免疫组化方法 ,检测各样本中ras/p2 1的表达 ,并与临床转移情况对照。结果 :ras/p2 1阳性和阴性者转移率分别为 75 .0 %、3 7.9% ( χ2=4.67,P <0 .0 5 ) ,介入治疗组及其A、B、C、D各组和单纯手术组 p2 1阳性率分别为 2 9.3 %、5 7.1%、2 5 .0 %、2 0 .0 %、2 7.3 %、61.4% (介入组分别与单纯手术组相比 ,χ2 值依次为 9.87、0 .0 4、3 .79、8.17、4.3 6,P值依次为 <0 .0 1、>0 .75、>0 .0 5、<0 .0 1、<0 .0 5 )。化疗栓塞使HCC各组织学类型及各病理分级ras/p2 1表达不同程度下降。介入组与单纯手术组转移率分别为 48.8%、5 6.1% ( χ2 =0 .5 2 ,P >0 .2 5 )。结论 :ras/ p2 1高表达可促进HCC转移 ,就ras/ p2 1而言 ,化疗栓塞可抑制HCC转移潜能 ,且碘油、无水乙醇、明胶海绵多材料联合化疗栓塞优于单一材料栓塞和单纯化疗。 Objective:To study the significance of ras/p21 gene expression of hepatocellular carcinoma (HCC), and the effect of the different chemoembolizational treatment on ras/p21.Methods:Ninety-eight histopathologically verified HCC specimens were obtained. The patients were treated with surgical resection alone (57 cases) and second stage surgical resection after four kinds of chemoembolization (41 cases). Strept avidin biotin complex (SABC) immunohistochemical staining with multiclonal antibody against human ras/p21 was used to observe the p21 in all specimens. The experimental results were compared with the surgical and clinical findings.Results:The metastatic rate in p21(+) and (-) was 75.0% and 37.9% respectively (χ 2=12.63,P<0.05);29.3% of chemoembolization group,57.1% of only chemotherapy, 25.0% of chemotherapy combined with iodized oil,20.0% of chemotherapy combined with iodized oil and spongia gelatini absorbens (sga),27.3% of chemotherapy combined with ethanol, iodized oil and sga,61.4% of surgical resection alone were positive for p21 (interventional groups were compared with surgical resection alone,P<0.01,>75,>05,<0.01,< 0.05, respectively).The metastatic rate in interventional group and surgical resection alone was 48.8% and 56.1% respectively (P>0.05).Conclusion:The increased expression of ras/p21 would enhance metastasis of HCC. It could act as a prognosis predictive marker. With respect to ras/p21, chemoembolization could suppress the potential of metastasis of HCC.Combined chemoembolization with ethanol, iodized oil and sga is superior to only chemotherapy and/or embolization with single material.
出处 《放射学实践》 2004年第7期474-476,共3页 Radiologic Practice
基金 国家自然科学基金资助项目 (30 0 70 2 35)
关键词 化疗栓塞 肝细胞癌 癌基因 ras/p21表达 HCC 免疫组织化学 Carcinoma,hepatocellular Embolization,therapeutic Gene expression ras gene Immunohitochemistry
  • 相关文献

参考文献11

  • 1胡中伟,曾明新.ras癌基因与肿瘤细胞转移潜能[J].国外医学(生理病理科学与临床分册),1998,18(3):279-281. 被引量:4
  • 2Cuatrecasas M,Erill N,Musulen E,et al. K-ras mutations in nonmucinous ovarian epithelial tumors:a molecular analysis and clinicopathologic study of 144 patients[J]. Cancer, 1998,82 (6) : 1088-1095.
  • 3Gonzalez AF, Deangelo AB, Nasim S, et al. Ras oncogene activation during hepatocarcinogenesis in B6 C3 Fl male mice by dichloroacetic and trichloroacetic acids[J]. Carcinogenesis, 1995,16(3):495-499.
  • 4Chiang JM,Chou YH,Chou TB,et al. K-ras codon 12 mutation determine the polypoid growth of colorectal cancer[J]. Cancer Res, 1998,58(15): 3289-3293.
  • 5Billadeau D,Jelinek DF,Shan N,et al. Introduction of an activated N-ras oncogene alters the growth chracteristics of the interleukin6 dependent myeloma cell line ANBL6[J]. Cancer Res, 1995,55(16):3640-3645.
  • 6Nemunatis T, Cox T, Meyer W, et al. Irinotecan hydrochlorde (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-Fluorouracil (5-Fu)[J]. Am J Clin Oncol (CCT) ,1997,20(5) :527-529.
  • 7Olson MF,Paterson HF,Marshall CJ. Signals from ras and rho G TPase interact to regulate expression of wafi/p21 [J]. Nature,1998,394(6690): 295-298.
  • 8Meade-Tellin LC,Boukamp P,Fusenig NE,et al. Differential expression of matrix metalloproteinase in activated H ras-transfected immortalized human keratinocytes[J]. Br J Cancer, 1998,77(5):724-730.
  • 9Nemunaitis J,Klemow S,Tong A,et al. Prognostic value of K-ras mutations,ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung[J]. Am J Clin Oncol (CCT), 1998,21(2) :155-160.
  • 10Kalkuhl A, Troppmair J, Buchmann A, et al. ras/p21 downstream effectors are increased in activity or expression in mouse liver tumors: but do not differ between ras-mutated and raswild-type lesions[J]. Hepatology, 1998,27(4): 1081-1088.

共引文献3

同被引文献23

  • 1SJ Moghaddam,EN Haghighi,S Samiee,N Shahid,AR Keramati,S Dadgar,MR Zali.Immunohistochemical analysis of p53,cyclinD1,RB1,c-fos and N-ras gene expression in hepatocellular carcinoma in Iran[J].World Journal of Gastroenterology,2007,13(4):588-593. 被引量:74
  • 2Castellucci P,Perrone A M,Picchio M.Diagnostic accuracy of 18T-FDG PET/CT inchaacterizing ovrian lesions and staging ovarian cancer:correlation with transvaginal ultrasonography,computed tomography,and hitology[J].Nucl Med Commun,2009,28(8):589-595.
  • 3Downward J.Targeting Ras signalling pathways in cancer therapy[J].Nature Reviews Cancer,2003,3(1):11-22.
  • 4Huang C,Liu D,Masuya D.Clinical application of biological markers for treatments of resectable non-small-cell lung cancers[J].Br J Cancer,2005,92(7):1231-1239.
  • 5Huang C L,Yokomise H,Kobayashi S.Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy[J].Int J Oncol,2000,17(1):47-54.
  • 6Shariat S F,Tokunaga H,Zhou J.p53,p21,pRB,and p16 expression predict clinical outcome in cystectomy with bladder cancer[J].J Clin Oncol,2004,22(6):1014-1024.
  • 7Aoyagi K,Kohfuji K,Yano S.The expression of proliferating cell nuclear antigen,p53,p21,and apoptosis in primary gastric lymphoma[J].Surgery,2002,132(1):20-26.
  • 8Calvisi D F,Ladu S,Gorden A.Ubiquitous activation of Ras and Jak/Stat pathways in human HCC[J].Gastroenterology,2006,130(4):1117-1128.
  • 9Bose S,Sakhuja P,Bezawada L.Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling[J].J Gastroenterol Hepatol,2011,26(1):135-144.
  • 10龚新雷,秦叔逵.原发性肝癌的分子靶向治疗研究新进展[J].临床肿瘤学杂志,2008,13(1):1-10. 被引量:26

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部